HAP Trading’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

HAP Trading’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-14,200	Closed	-$35K	–	2929
2021 Q2	$35K	Buy	+14,200	New	+$279K	﹤0.01%	1618
2021 Q1	–	Sell	-10,400	Closed	-$12K	–	2757
2020 Q4	$12K	Buy	+10,400	New	+$186K	﹤0.01%	1870

HAP Trading's TBIO Position: Q1 2021 in Review

HAP Trading sold out of Translate Bio, Inc. Common Stock (TBIO) in Q1 2021, closing a stake of 16,703 shares — an estimated $308K sold.

HAP Trading first reported a position in TBIO in Q4 2020 and held it in 1 quarter. The position peaked at $308K in Q4 2020. 146 funds tracked by Wall St. Rank hold TBIO as of Q1 2021.

HAP Trading reported no remaining Translate Bio, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
HAP Trading sold 16,703 Translate Bio, Inc. Common Stock shares in Q1 2021, an estimated $308K.
HAP Trading first reported a position in Translate Bio, Inc. Common Stock in Q4 2020 and held it in 1 quarter.
HAP Trading's Translate Bio, Inc. Common Stock position peaked at $308K in Q4 2020.
146 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q1 2021.

Based on HAP Trading's 13F filing for Q1 2021, filed 14 May 2021.